I'm sure she's tired of having this pointed out, but the executive director of biotechnology company Bio/Start is named Carol Frankenstein. A story quoting her is here:
"We do 25 percent of the clinical trials in the U.S. in Ohio," she said, noting that Ohio's hospitals, research institutions and its population make it an ideal environment for such study.
I wonder what kind of dark and nefarious research that
would be. Let's not wait, Howard
, until it's too late to find out. Gather an angry mob and pass out the torches.